United KingdomA study published in Molecular Oncology has identified specific circulating microRNAs that could serve as biomarkers for detecting cancer-associated cachexia in senior dogs. Researchers analyzed blood samples from 25 senior dogs and found decreased levels of miR-15a, miR-15b, miR-16, and miR-140 in dogs with cachexia, with miR-16 showing the strongest correlation. Female dogs with cancer had particularly low levels of miR-140, which has anti-inflammatory properties, suggesting a potential link between estrogen-related cancers and suppressed miR-140 expression. The findings highlight the possibility of using these microRNAs for early detection and treatment strategies for cachexia in both veterinary and human medicine, leveraging the biological similarities between dogs and humans.
Bias read (Center): The article discusses scientific research related to canine health and does not present any politically charged subject matter. It focuses on medical advancements and biological research without taking a stance or showing bias toward any political ideology.
